Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-19-003822)

Filing Details

Accession Number:: 0000899243-19-003822
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-15 06:05:21
Reporting Period:: 2019-02-13

Accepted Time:: 2019-02-15 06:05:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	Pharmaceutical Preparations (2834)	I0

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1121404	Sanofi	54 Rue La Boetie Paris I0 75008		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock (Par Value $0.0001)	Disposition	2019-02-13	4,168,899	$37.66	0	No	4	S	Indirect	Via wholly-owned subsidiary, Aventis Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Via wholly-owned subsidiary, Aventis Inc.

Footnotes

On February 13, 2019, the reporting person sold 4,168,899 shares of MYOK at a price of $37.66 (the "Transaction"). As a result of the Transaction, the reporting person no longer owns shares of common stock of MYOK and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of MYOK.